About Walking Fish Therapeutics
Walking Fish Therapeutics is a company based in San Francisco (United States) founded in 2019 by Seenu Kothakota, Lewis T Williams, Mark Selby, and Tom Brennan.. Walking Fish Therapeutics has raised $123 million across 2 funding rounds from investors including Northpond Ventures, First Spark Ventures and TMCP. Walking Fish Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Francisco, United States
- Founders Seenu Kothakota, Lewis T Williams, Mark Selby, Tom Brennan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Walking Fish Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$123 M (USD)
in 2 rounds
-
Latest Funding Round
$73 M (USD), Series A
Feb 16, 2022
-
Investors
Northpond Ventures
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Walking Fish Therapeutics
Walking Fish Therapeutics has successfully raised a total of $123M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $73 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $73.0M
-
First Round
First Round
(13 Sep 2021)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Series A - Walking Fish Therapeutics | Valuation | Northpond Ventures , First Spark Ventures | |
| Sep, 2021 | Amount | Series A - Walking Fish Therapeutics | Valuation | Emerson Collective , Illumina Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Walking Fish Therapeutics
Walking Fish Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Northpond Ventures, First Spark Ventures and TMCP. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Founded Year | Domain | Location | |
|
Private equity investments in China are managed by TMCP.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Walking Fish Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Walking Fish Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Walking Fish Therapeutics Comparisons
Competitors of Walking Fish Therapeutics
Walking Fish Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Walking Fish Therapeutics
Frequently Asked Questions about Walking Fish Therapeutics
When was Walking Fish Therapeutics founded?
Walking Fish Therapeutics was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Walking Fish Therapeutics located?
Walking Fish Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Walking Fish Therapeutics?
Lewis T Williams is the current CEO of Walking Fish Therapeutics. They have also founded this company.
Is Walking Fish Therapeutics a funded company?
Walking Fish Therapeutics is a funded company, having raised a total of $123M across 2 funding rounds to date. The company's 1st funding round was a Series A of $50M, raised on Sep 13, 2021.
What does Walking Fish Therapeutics do?
Walking Fish Therapeutics was founded in 2019 in San Francisco, United States, within the biotechnology sector. Cell-based solutions are developed to address cancer and immunological disorders. Proprietary technology based on B cells and their derivatives is used to generate therapeutic proteins, including antibodies for infectious diseases, replacement proteins for deficiencies, immune-inhibitory proteins for autoimmune conditions, and regenerative proteins. Antigens are supplied to support antitumor immune responses in oncology applications.
Who are the top competitors of Walking Fish Therapeutics?
Walking Fish Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Walking Fish Therapeutics's investors?
Walking Fish Therapeutics has 6 investors. Key investors include Northpond Ventures, First Spark Ventures, TMCP, Emerson Collective, and Illumina Ventures.